Financials

  • Market Capitalization 8.64 B
  • Employee 399
  • Founded 1993
  • CEO Michael S Weiss
  • Website www.tgtherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000FVZQY1
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
20.05
Rapporto prezzo/fatturato
10.98

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
973
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
84.95 USD0.00%+0.12%+1.53%+106.69%9.01 B USD
986
ABVX
Abivax SA - American Depositary Shares
112.31 USD-1.20%-4.69%-6.72%+36.33%8.82 B USD
1015
APGE
Apogee Therapeutics, Inc. - Common Stock
135.08 USD0.00%+0.09%+0.72%+152.06%8.40 B USD
1025
IBRX
ImmunityBio, Inc. - Common Stock
7.82 USD-0.64%-5.10%+8.91%+227.20%8.29 B USD

Notizie